Amgen (AMGN) March put volatility at 24, June at 30 into data
Tweet Send to a Friend
Amgen (Nasdaq: AMGN) closed at $59.23. Phase 3 data for Prolia (denosumab) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
